AI Science Tracker
EN

Development and validation of a noninvasive machine learning model using urinary extracellular vesicle physical parameters for prostate cancer diagnosis.

The Second Affiliated Hospital of Fujian Medical University; Beijing Shijitan Hospital; Capital Medical University · 29 May 2026 · medicine

Discovery

Development and validation of a noninvasive machine learning model using urinary extracellular vesicle physical parameters for prostate cancer diagnosis.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine learning used physical measurements of urinary extracellular vesicles to distinguish prostate cancer from benign prostatic hyperplasia in a three-hospital biopsy cohort.

Technology: Five ML algorithms use urinary extracellular-vesicle physical measurements in 222 biopsy-indicated patients recruited at three centers (65 pathology-confirmed cancer, 157 BPH); model predicts cancer status as a possible adjunct biomarker.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Five ML algorithms use urinary extracellular-vesicle physical measurements in 222 biopsy-indicated patients recruited at three centers (65 pathology-confirmed cancer, 157 BPH); model predicts cancer status as a possible adjunct biomarker.
Test and result
The study compared five algorithms against biopsy pathology in 222 patients, including 65 with cancer. It drew its 67-patient test set from the same cohort.
Limitation / still unknown
No external-site test was reported. The study did not establish whether the model improves biopsy decisions.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-026-54920-3

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.